REVIEW article
Front. Public Health
Sec. Digital Public Health
This article is part of the Research TopicInternet of Things (IoT) and Artificial Intelligence in Public Health: Challenges, Barriers and OpportunitiesView all 3 articles
AI-Driven Transformation of Precision Medicine: A Comprehensive Narrative Review of Key Application Areas, Emerging Paradigms, and Future Directions
Provisionally accepted- 1West China Second University Hospital, Sichuan University, Chengdu, China
- 2Sichuan University West China Second University Hospital Department of Nursing, Chengdu, China
- 3West China Hospital of Sichuan University, Chengdu, China
- 4Sichuan University West China Second University Hospital, Chengdu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objectives: This study aims to elucidate the pivotal role of Artificial Intelligence (AI) in driving the transformation of precision medicine, comprehensively analyzing how it reshapes healthcare systems from traditional diagnosis and treatment paradigms into personalized health management ecosystems. Methods: A comprehensive narrative review was conducted to systematically synthesize and critically evaluate the innovative applications, paradigm shifts, and future prospects of AI across the entire precision medicine value chain. A comprehensive literature search was performed across multiple databases up to April 30, 2025, with a focus on the clinical implementation and breakthroughs of technologies such as deep learning (DL), machine learning (ML), and natural language processing (NLP). Results: AI technologies have significantly enhanced the accuracy and efficiency of disease diagnosis through medical image analysis, genomics, and multimodal data fusion. At the treatment level, AI enables the development of personalized therapeutic plans and drug dosing optimization, while revolutionarily accelerating the drug development pipeline from discovery to clinical trials. Integrated with wearable devices and telemedicine platforms, AI facilitates full-cycle health monitoring. However, the clinical translation of AI faces challenges, including an uneven evidence base, insufficient model generalizability, and ethical concerns regarding data privacy, algorithmic fairness, and interpretability. Conclusion: AI is a key driver of paradigm shift in precision medicine. To address existing challenges, future efforts should focus on generating more robust clinical evidence, adopting technologies like federated learning to ensure data privacy, and promoting the human-centered, collaborative framework of Symbiotic AI (SAI). By establishing sound ethical and governance structures, the deployment of AI technologies can be ensured to be not only efficient and advanced but also equitable and trustworthy, ultimately paving the way for an intelligent and inclusive healthcare ecosystem.
Keywords: artificial intelligence, deep learning, healthcare ethics, personalized treatment, precision medicine, remote monitoring, Symbiotic Artificial Intelligence
Received: 30 Jun 2025; Accepted: 08 Dec 2025.
Copyright: © 2025 Zeng, Cheng and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jun Zhu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
